ERIS Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|
Revenue | 421.52 | 407.52 | 442.37 |
Operating Expense | 283.80 | 300.16 | 293.93 |
Net Profit | 30.47 | 1.78 | 28.10 |
Net Profit Margin | 7.23 | 0.44 | 6.35 |
Earning Per Share | 2.24 | 0.13 | 2.06 |
EBIDTA | 135.52 | 103.11 | 139.30 |
Effective Tax Rate | 6.18 | TBA | 5.91 |
Particulars | Mar 2025 |
---|---|
Revenue | 421.52 |
Operating Expense | 283.80 |
Net Profit | 30.47 |
Net Profit Margin | 7.23 |
Earning Per Share | 2.24 |
EBIDTA | 135.52 |
Effective Tax Rate | 6.18 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 1,697.75 | 1,486.71 | 1,330.73 |
Operating Expenses Annual | 1,211.20 | 1,032.89 | 825.61 |
Operating Profit Annual | 522.06 | 488.65 | 522.38 |
Interest Annual | 220.24 | 57.42 | 20.81 |
Depreciation | 47.31 | 34.15 | 29.76 |
Net Profit Annual | 77.39 | 299.72 | 398.01 |
Tax Annual | 42.66 | 29.12 | 38.90 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 1,697.75 |
Operating Expenses Annual | 1,211.20 |
Operating Profit Annual | 522.06 |
Interest Annual | 220.24 |
Depreciation | 47.31 |
Net Profit Annual | 77.39 |
Tax Annual | 42.66 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 51.93 | 47.48 | 44.70 |
Cash Flow from Operations | 701.86 | 336.29 | 322.33 |
Cash Flow from Investing | -358.99 | -2,491.89 | -513.30 |
Cash Flow from Financing | -310.46 | 2,160.05 | 193.75 |
Cash Flow at the End | 84.34 | 51.93 | 47.48 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 51.93 |
Cash Flow from Operations | 701.86 |
Cash Flow from Investing | -358.99 |
Cash Flow from Financing | -310.46 |
Cash Flow at the End | 84.34 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 30.64 | 31.97 | 38.97 |
PBIT Margin (%) | 19.97 | 25.27 | 34.15 |
PBT Margin (%) | 19.88 | 24.83 | 32.51 |
Net PROFIT Margin (%) | 4.54 | 19.61 | 29.69 |
Return On Networth / Equity (%) | 3.07 | 12.63 | 19.23 |
Return On Networth /Employed (%) | 6.83 | 9.97 | 19.94 |
Return On Assets (%) | 1.54 | 7.65 | 17.22 |
Total Debt / Equity (X) | 0.96 | 0.61 | 0.08 |
Asset Turnover Ratio (%) | 0.34 | 0.39 | 0.58 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 30.64 |
PBIT Margin (%) | 19.97 |
PBT Margin (%) | 19.88 |
Net PROFIT Margin (%) | 4.54 |
Return On Networth / Equity (%) | 3.07 |
Return On Networth /Employed (%) | 6.83 |
Return On Assets (%) | 1.54 |
Total Debt / Equity (X) | 0.96 |
Asset Turnover Ratio (%) | 0.34 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 2,412.45 | 1,516.17 | 898.16 |
Total Current Assets Annual | 627.54 | 1,876.54 | 552.08 |
Non Current Assets Annual | 4,594.89 | 3,473.03 | 2,231.58 |
Total Shareholders Funds Annual | 2,514.90 | 2,524.02 | 2,221.88 |
Total Assets Annual | 5,222.43 | 5,349.57 | 2,783.66 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 2,412.45 |
Total Current Assets Annual | 627.54 |
Non Current Assets Annual | 4,594.89 |
Total Shareholders Funds Annual | 2,514.90 |
Total Assets Annual | 5,222.43 |
EPS (INR)
Expected
6.89
Reported
6.90
Surprise
0.15%
Dec 2024
EPS beaten by 0.15%
Sep 2024
EPS beaten by 0.16%
Jun 2024
EPS beaten by 0.00%